Page last updated: 2024-08-17

medroxyprogesterone acetate and Cancer of Pelvis

medroxyprogesterone acetate has been researched along with Cancer of Pelvis in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (62.50)	18.7374
1990's	1 (12.50)	18.2507
2000's	2 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dörken, B; Kretzschmar, A; Lindner, T; Mrozek, A; Pink, D; Reichardt, P; Thuss-Patience, PC	1
Baltar Arias, R; Castro Ortiz, E; Fernández Salgado, E; Ibáñez Pinto, A; Ledo Barro, L; Vázquez Astray, E; Vázquez San Luis, J; Vázquez Vázquez, S	1
Cedars, MI; Judd, HL; Lu, JK; Meldrum, DR	1
Manart, FD; Montag, TW	1
Fåhraeus, L; Sydsjö, A; Wallentin, L	1
Hayes, MF; Hull, ME; Magyar, DF; Moghissi, KS	1
Cremer, P; Kuhn, W; Seidel, D; Teichmann, AT; Wieland, H	1
Kauppila, A; Puolakka, J; Rönnberg, L; Telimaa, S	1

Reviews

1 review(s) available for medroxyprogesterone acetate and Cancer of Pelvis

Article	Year
[Gastrointestinal bleeding of obscure origin caused by a metastatic endometrial adenocarcinoma. Response to hormonal therapy]. Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:9 Topics: Aged; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Neoplasms; Female; Gastrointestinal Hemorrhage; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Pelvic Neoplasms; Peritoneal Neoplasms; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Umbilicus	2007

Article

Year

[Gastrointestinal bleeding of obscure origin caused by a metastatic endometrial adenocarcinoma. Response to hormonal therapy].

Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:9

Topics: Aged; Antineoplastic Agents, Hormonal; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Neoplasms; Female; Gastrointestinal Hemorrhage; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Pelvic Neoplasms; Peritoneal Neoplasms; Retroperitoneal Neoplasms; Tomography, X-Ray Computed; Umbilicus

2007

Trials

1 trial(s) available for medroxyprogesterone acetate and Cancer of Pelvis

Article	Year
Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1987, Volume: 1, Issue:1 Topics: Adult; Antineoplastic Agents; Clinical Trials as Topic; Danazol; Dose-Response Relationship, Drug; Double-Blind Method; Endometriosis; Female; Humans; Infertility, Female; Laparoscopy; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Pelvic Neoplasms; Pregnadienes; Pregnancy; Random Allocation	1987

Article

Year

Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1987, Volume: 1, Issue:1

Topics: Adult; Antineoplastic Agents; Clinical Trials as Topic; Danazol; Dose-Response Relationship, Drug; Double-Blind Method; Endometriosis; Female; Humans; Infertility, Female; Laparoscopy; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovarian Neoplasms; Pelvic Neoplasms; Pregnadienes; Pregnancy; Random Allocation

1987

Other Studies

6 other study(ies) available for medroxyprogesterone acetate and Cancer of Pelvis

Article	Year
Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature. Gynecologic oncology, 2006, Volume: 101, Issue:3 Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Endometrial Stromal Tumors; Estrogen Replacement Therapy; Female; Humans; Letrozole; Medroxyprogesterone Acetate; Middle Aged; Nitriles; Pelvic Neoplasms; Peritoneal Neoplasms; Retrospective Studies; Tamoxifen; Triazoles; Uterine Neoplasms	2006
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. Obstetrics and gynecology, 1990, Volume: 75, Issue:4 Topics: Adult; Drug Therapy, Combination; Endometriosis; Estradiol; Estrone; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Pain; Pelvic Neoplasms	1990
Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence. Gynecologic oncology, 1989, Volume: 33, Issue:2 Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Delayed-Action Preparations; Estrogens, Conjugated (USP); Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Pelvic Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Renal Veins; Sarcoma; Uterine Neoplasms; Vena Cava, Inferior	1989
Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate. Fertility and sterility, 1986, Volume: 45, Issue:4 Topics: Adult; Cholesterol, HDL; Delayed-Action Preparations; Endometriosis; Female; Humans; Lipoproteins; Medroxyprogesterone; Medroxyprogesterone Acetate; Pelvic Neoplasms; Phospholipids; Triglycerides	1986
Comparison of different treatment modalities of endometriosis in infertile women. Fertility and sterility, 1987, Volume: 47, Issue:1 Topics: Adult; Antineoplastic Agents; Danazol; Endometriosis; Female; Follow-Up Studies; Humans; Infertility, Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Pelvic Neoplasms; Pregnadienes	1987
Lipid metabolic changes during hormonal treatment of endometriosis. Maturitas, 1988, Volume: 10, Issue:1 Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Danazol; Endometriosis; Female; Humans; Lipid Metabolism; Lynestrenol; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pelvic Neoplasms; Pregnadienes; Time Factors; Triglycerides	1988